1967
DOI: 10.1093/oxfordjournals.aje.a120684
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Immunity to Diphtheria and Tetanus: A Mathematical Model1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

1967
1967
2009
2009

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Furthermore, earlier models of antibodies to hepatitis B, tetanus, and diphtheria toxoids have shown a clear slowing of the decline with diminishing concentration, i.e. with time since response [36,37]. This slowing, together with the effect of new stimuli, helps to explain the stability of adult Hib antibody concentration levels, the mean concentration in many populations being around 1-2 µg\ml [15,27,38,39].…”
Section: Duration Of Immunity To Invasive Diseasementioning
confidence: 92%
“…Furthermore, earlier models of antibodies to hepatitis B, tetanus, and diphtheria toxoids have shown a clear slowing of the decline with diminishing concentration, i.e. with time since response [36,37]. This slowing, together with the effect of new stimuli, helps to explain the stability of adult Hib antibody concentration levels, the mean concentration in many populations being around 1-2 µg\ml [15,27,38,39].…”
Section: Duration Of Immunity To Invasive Diseasementioning
confidence: 92%
“…However, other studies (Gottlieb, Martin & McLaughlin, 1967;Trinca, 1975) which also looked at the fall of antibody levels suggest that the duration of immunity to diphtheria is long. In this present study of a normal New Zealand population, there was generally a gradual fall in antibody levels with increasing age.…”
Section: Discussionmentioning
confidence: 98%
“…Quantification of the antibody response is important in predicting the longevity of clinical Up to 5 per cent of those vaccinated are reported as initial Many of them respond to subsequent booster doses.71 Other techniques are currently being developed to encourage seroconversion in poor responder^.^^.^^ Individuals in whom anti-HBs cannot be detected despite initial vaccination and subsequent boosters remain at risk of contracting HBV. 65,70 It is currently accepted that an antibody level of 10 mIU/mL is the minimum required for clinical immunity.15.S7. 64.66.69 The rationale for booster vaccination in normal responders is based on an exponential decline in antibody titres as occurs with other vaccines such as tetanus t o x~i d .~~…”
Section: Immunization Against Hbvmentioning
confidence: 99%